Simon, Christopher has filed 19 insider transactions across 2 companies since March 2024.
Most recent transaction: a grant/award of 66666 shares of HAEMONETICS CORP ($HAE) on May 30, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 30, 2025 | HAEMONETICS CORP | $HAE | Simon, Christopher | President & CEO | A | Common Stock | 66666 | $0.00 | 401,778.0000 | 50,730,000 | 19.89% | 0.13% |
| May 30, 2025 | HAEMONETICS CORP | $HAE | Simon, Christopher | President & CEO | F | Common Stock | 26234 | $69.38 | 375,544.0000 | 50,730,000 | 6.53% | 0.05% |
| May 22, 2025 | Sotera Health Co | $SHC | Simon, Christopher | Not found | A | Common Stock, $0.01 par value per share ("Common Stock") | 19132 | $0.00 | 19,132.0000 | 284,906,000 | 9999.99% | 0.01% |
| May 16, 2025 | HAEMONETICS CORP | $HAE | Simon, Christopher | President & CEO | A | Non-qualified Stock Option (Right to Buy) | 46342 | $0.00 | 46,342.0000 | 50,730,000 | 9999.99% | 0.09% |
| May 16, 2025 | HAEMONETICS CORP | $HAE | Simon, Christopher | President & CEO | A | Common Stock | 21405 | $0.00 | 335,112.0000 | 50,730,000 | 6.82% | 0.04% |
| May 16, 2025 | HAEMONETICS CORP | $HAE | Simon, Christopher | President & CEO | F | Common Stock | 7089 | $70.31 | 313,707.0000 | 50,730,000 | 2.21% | 0.01% |
| May 15, 2025 | HAEMONETICS CORP | $HAE | Simon, Christopher | President & CEO | F | Common Stock | 2391 | $69.38 | 320,796.0000 | 50,730,000 | 0.74% | 0.00% |
| Aug. 29, 2024 | HAEMONETICS CORP | $HAE | Simon, Christopher | President & CEO | J | Common Stock | 39704 | $75.56 | 322,838.0000 | 51,397,000 | 10.95% | 0.08% |
| June 6, 2024 | HAEMONETICS CORP | $HAE | Simon, Christopher | President & CEO | F | Common Stock | 71335 | $87.38 | 362,542.0000 | 51,397,000 | 16.44% | 0.14% |
| June 6, 2024 | HAEMONETICS CORP | $HAE | Simon, Christopher | President & CEO | M | Non-qualified Stock Option (Right to Buy) | 104516 | $0.00 | 0.0000 | 51,397,000 | 100.00% | 0.20% |
| June 6, 2024 | HAEMONETICS CORP | $HAE | Simon, Christopher | President & CEO | M | Common Stock | 104516 | $41.64 | 433,877.0000 | 51,397,000 | 31.73% | 0.20% |
| May 28, 2024 | HAEMONETICS CORP | $HAE | Simon, Christopher | President & CEO | F | Common Stock | 41736 | $95.73 | 329,361.0000 | 51,397,000 | 11.25% | 0.08% |
| May 28, 2024 | HAEMONETICS CORP | $HAE | Simon, Christopher | President & CEO | A | Common Stock | 106062 | $0.00 | 371,097.0000 | 51,397,000 | 40.02% | 0.21% |
| May 17, 2024 | HAEMONETICS CORP | $HAE | Simon, Christopher | President & CEO | A | Common Stock | 14624 | $0.00 | 265,035.0000 | 51,397,000 | 5.84% | 0.03% |
| May 17, 2024 | HAEMONETICS CORP | $HAE | Simon, Christopher | President & CEO | A | Non-qualified Stock Option (Right to Buy) | 32140 | $0.00 | 32,140.0000 | 51,397,000 | 9999.99% | 0.06% |
| May 17, 2024 | HAEMONETICS CORP | $HAE | Simon, Christopher | President & CEO | F | Common Stock | 4037 | $95.73 | 250,411.0000 | 51,397,000 | 1.59% | 0.01% |
| May 15, 2024 | HAEMONETICS CORP | $HAE | Simon, Christopher | President & CEO | F | Common Stock | 1480 | $96.49 | 256,355.0000 | 51,397,000 | 0.57% | 0.00% |
| May 16, 2024 | HAEMONETICS CORP | $HAE | Simon, Christopher | President & CEO | F | Common Stock | 1907 | $94.80 | 254,448.0000 | 51,397,000 | 0.74% | 0.00% |
| March 11, 2024 | HAEMONETICS CORP | $HAE | Simon, Christopher | President & CEO | G | Common Stock | 38900 | $0.00 | 257,546.0000 | 51,420,000 | 13.12% | 0.08% |